 prospect comparison esophag varic sclerotherapi agent sodium tetradecyl sulfat versu sodium morrhuat prospect random studi differ efficaci complic rate scleros agent sodium tetradecyl sulfat std sodium morrhuat mor patient acut index varic std mor dextros overal mortal std group mor group NS control acut bleed std patient mor patient NS overal obliter std group mor group patient studi month obliter NS trend rebleed std group mor group signific differ std mor patient regard transfus requir units/pati units/pati ulcer strictur format result studi std mor equival solut bia use agent